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Received November 18, 2014; accepted December 31, 2014AbstractBackground: Conventional karyotyping has been a routine method to identify chromosome abnormalities in products of conception. However,
this process is being transformed by single nucleotide polymorphism (SNP) array, which has advantages over karyotyping, including higher
resolution and dispensing with cell culture. Therefore, the purpose of this study was to evaluate the advantage of high-resolution SNP array in
identifying genetic aberrations in products of conception.
Methods: We consecutively collected 155 products of conception specimens, including 139 from first-trimester miscarriage and 16 from second-
trimester miscarriage. SNP array was performed on these samples in parallel with G-banded karyotyping.
Results: The test success rate was 98.1% (152/155) using SNP array, which was higher than that using karyotyping (133/155, 85.8%). It yielded a
63.8% (97/152) abnormality rate, and the frequency of various chromosome abnormalities was in agreement with other previous studies. The
results between array and karyotyping demonstrated a 94.0% (125/133) concordance. SNP array obtained additional aberrations in 3.8% (5/133)
of those cases unidentified by karyotyping, which included three cases with whole-genome uniparental disomy, one with pathogenic copy
number variation, and one with del(4)(q35.1q35.2) and dup(12)(q24.31q24.33). However, chromosome translocations presented in two cases and
tetraploidy presented in one case were detected by karyotyping instead of array. Additionally, two out of three cases with mosaic trisomy were
revealed by array but recognized as pure trisomy by karyotyping.
Conclusion: This study demonstrated that SNP array had certain advantages over G-banded karyotyping, including a higher success rate,
additional detection of copy number variations and uniparental disomy, and improved sensitivity to mosaicism. Therefore, it would be an
alternative method to karyotyping in clinical genetic practice.
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Miscarriage is the spontaneous loss of pregnancy before 24
completed weeks of gestation.1 Approximately 10e15% of all
clinically recognized pregnancies end in miscarriage, mostly
during the first trimester (up to 12 weeks' gestation).2
Although many risk factors relate to this occurrence, genetic
factors play the most important role. In addition, cytogenetic
analysis of products of conception (POC) from miscarriageociation. All rights reserved.
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bryonic chromosome abnormalities accounts for approxi-
mately 50% of first-trimester miscarriage, of which there were
86% numerical abnormalities, 6% structural abnormalities,
and 8% other chromosome abnormalities such as mosaicism or
double and triple trisomies.3 In the past several decades,
chromosomal karyotyping has been used as the standard to
detect microscopic chromosome aberrations in POC. It is
crucial for chromosomal karyotyping to collect sterile speci-
mens with sufficient viable cells of the villi, which often de-
pends on the duration of embryo or fetus death, and the
manner of acquiring POC samples. In addition, because of its
technique limitations, such as high rate (5e42%) of tissue-
culture failure,4 poor chromosome preparations, possible
maternal cell contamination, low resolution, and high turn-
around time, the genetic causes of miscarriage have not been
fully elucidated in clinical practice. Recently, however, chro-
mosomal microarray analysis (CMA), including array-based
comparative genomic hybridization (array-CGH) and single
nucleotide polymorphism (SNP) array, is increasingly being
applied to the analysis of POC. Due to the advantages of
reduced requirements regarding sample quality and improved
resolution, DNA-based CMA may overcome many of the
limitations existing in karyotyping. Previous studies using
array-CGH for investigation of POC indicated that array-CGH
could detect an additional 5% of copy number variations
(CNVs) that remained undetectable for karyotyping.2,5e10
Furthermore, Lathi et al11 successfully applied another
CMA platform of SNP array to the analysis of 30 POC
specimens, and reached 87% accordance with G-banded kar-
yotyping. Recently, Levy et al12 found that clinically signifi-
cant CNVs and whole-genome uniparental disomy (UPD) in
1.6% and 0.4% of POC specimens, respectively, by also using
SNP array. However, in contrast to karyotyping, there are
relatively few applications of SNP array in the clinical
investigation of POC. As limited data are available on the
clinical utility of CMA as a routine method to evaluate first-
and second-trimester miscarriage,13 more studies are required
for assessing its value of clinical routine application at this
time. Therefore, to evaluate the advantage of high-resolution
SNP array in identifying genetic aberrations in POC, this
study compared it with conventional G-banded karyotyping by
analyzing 155 POC samples derived from first- and second-
trimester (12e24 weeks' gestation) miscarriage.
2. Methods2.1. CasesA total of 155 cases diagnosed as missed abortion under-
went the dilation and curettage procedure from July 2013 to
April 2014. All 155 POC specimens, including 139 from first-
trimester miscarriage (mean gestational age was 8.9 weeks,
ranging from 6 weeks to 12 weeks) and 16 from second-
trimester miscarriage (mean gestational age was 15.9 weeks,
ranging from 13 weeks to 19 weeks) were collected consec-
utively. Among 139 cases from first-trimester miscarriage, 95were diagnosed with a missed miscarriage and 44 with a
blighted ovum. All women had spontaneous conception with
singleton pregnancy. The mean age of women was 32.2 years,
with a range 22e45 years. Of the 155 cases, 116 cases were
without prior miscarriages or with one prior miscarriage (also
called sporadic miscarriage), 32 cases had equal to or more
than two prior miscarriages (also called recurrent miscarriage),
and seven had an unknown history of miscarriage. Prior to the
initial study, the Medical Ethics Committee of our hospital
checked and approved the research program. All women gave
consent for the execution of the cytogenetic and molecular
cytogenetic investigation on the POC and signed written
informed consent forms saved in medical records after being
reviewed by the Medical Ethics Committee.2.2. Specimen preparationWe examined POC specimens grossly in part for the purpose
of excluding specimens that consisted only of placental decidua
and, thereafter, acquired a small portion of chorionic villi. Then
it was washed with 0.9% normal saline at least three times to
clean out visible blood clots, and separated by forceps from
maternal decidua, blood vessels, blood clots, membrane, and
other materials under a dissecting microscope. Thereafter,
another laboratory technologist performed a similar procedure
on the preliminary selected samples, to ensure that most fetal
chorionic villi were isolated from maternal tissues.
Although SNP array is supposed to reveal potential
maternal cell contamination in POC by acquiring parental
specimens that are analyzed simultaneously, it would be un-
affordable to patients and difficult to perform in a clinical
environment. Therefore, we did not adopt this means in our
study. However, it was expected that the potential maternal
cell contamination in selected villus samples would be mini-
mal in our sample processing technique, as referenced above.
Each selected chorionic villus was cut into pieces and then
divided into three parts: one-third was used for cell culture and
subsequent G-banded karyotyping or metaphase fluorescence in
situ hybridization (FISH), one-third for DNA extraction and SNP
array analysis, and the remaining one-third was disaggregated
using 60% acetic acid and stored at 20C after being fixed by
methanol/acetic acid (ratio 3:1) for interphase FISH.2.3. Conventional karyotyping analysisCell culture and routine G-banded karyotyping were per-
formed according to standard protocols. The International
System for Human Cytogenetic Nomenclature 2009 was uti-
lized to help define chromosome abnormalities. In addition,
karyotyping results were blinded to the experimenters before
SNP array analysis was performed.2.4. SNP array analysisGenomic DNAwas isolated from uncultured chorionic villus
cells with QIAamp DNA mini kit (Qiagen, Valencia, CA, USA)
according to the manufacturer's instructions. DNA samples
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following the manufacturer's protocol. The Affymetrix Cyto-
Scan 750K array contains >750,000 markers for copy number
analysis, of which 550,000 are unique nonpolymorphic oligo-
nucleotide probes and 200,000 SNP probes that can be used for
genotyping. Average marker spacing is one probe every 4.1 kb,
with a mean spacing of one probe every 6.1 kb on nongene
backbone and one probe every 1.7 kb in intragenic regions.
Aberrations were filtered by the Affymetrix ChAS 2.0 software
up to a minimal size of 200 kb and at least 50-probe calls for
deletions and duplications. ChAS was designed to reliably
detect only mosaicism between approximately 30% and 70%
for CNVs  5 Mb in size. In addition, this software for 750K
arrays was set for displaying loss of heterozygosity of  3 Mb
in size, and a cutoff of a single loss of heterozygosity of >
10 Mb on a single chromosome was used for indicating UPD.
Results were analyzed manually for CNVs and loss of hetero-
zygosity. All data had to meet the Quality Control (QC) metrics
including SNPQC  15, Median of the Absolute values of all
Pairwise Differences (MAPD)  0.25, and waviness standard
deviation (SD)  0.12. A cutoff of 10 Mb in size was used to
distinguish CNV ( 10 Mb) from cytogenetically chromosomal
deletion or duplication (> 10 Mb).14
We compared all observed CNVs with those catalogued in
the Database of Genomic Variants (DGV) and the Database of
Chromosomal Imbalance and Phenotype in Humans using
Ensemble Resources (DECIPHER), and then classified CNVs
as common CNVs and unique CNVs. Common CNVs were
defined as those that overlapped completely with CNVs re-
ported in at least one study catalogued in the DGV with > 100
cases studied and a frequency of  1%, or at least two studies
catalogued in the DGV.Unique CNVswere defined as those that
showed no or incomplete overlap with CNVs in the DGV, or that
are presented in the DGV, but with < 100 cases studied and/or a
frequency of < 1%.5,15 The building of the human genome as-
sembly was based on GRCH37/hg19. Unique CNVs were
assessed by searching for similar cases in DECIPHER and
PubMed, and also by searching for gene information in Entrez
Gene and OMIM.We also classified unique CNVs according to
categories of clinical significance recommended by the Amer-
ican College of Medical Genetics. It categorizes CNVs into
pathogenic variations, benign variations, and variations of un-
certain clinical significance (VOUS), and VOUS can be further
subdivided into likely pathogenic, likely benign and VOUS.16
Besides, the results of mosaicism or pathogenic CNVs were
verified by interphase or metaphase FISH.2.5. Statistical analysisSPSS version 13 forWindows (SPSS Inc., Chicago, IL,USA)
was utilized to perform statistical analysis of theChi-square test.
A p value < 0.05 was considered statistically significant.
3. Results
G-banded karyotyping and SNP array were performed on
155 POC samples concurrently. Finally, karyotyping wassuccessfully performed on 133 cases but failed in 22 cases due
to failed cell culturing, while SNP array was successfully
analyzed in 152 cases and failed in three cases because of
substandard QC metrics, which probably resulted from poor
DNA quality. Overall, SNP array yielded a 63.8% (97/152)
abnormality rate. The abnormality rate (84/116, 72.4%) in
sporadic miscarriage cases was higher than that rate (13/32,
40.6%) in recurrent miscarriage cases ( p ¼ 0.001). However,
SNP array results either from first-trimester (90/136, 66.2%)
and second-trimester (7/16, 43.8%) miscarriage ( p ¼ 0.077),
or from missed miscarriage (62/92, 67.4%) and blighted ovum
(28/44, 63.6%) ( p ¼ 0.665) showed no difference. Fig. 1
demonstrated the frequency of various aberrations detected
by SNP array. Of these abnormalities (n ¼ 97), the most
common were aneuploidies, primarily including trisomy 16
(23.7%, 23/97), monosomy X (11.3%, 11/97), trisomy 22
(10.3%, 10/97), triploidy (6.2%, 6/97), trisomy 13 (5.2%, 5/
97), trisomy 21 (4.1%, 4/97), trisomy18 (4.1%, 4/97), and
trisomy 4 (4.1%, 4/97).
The overall test success rate was 98.1% (152/155) in SNP
array and 85.8% (133/155) in karyotyping. A total of 133
cases were successfully analyzed by SNP array and kar-
yotyping, and the results demonstrated 94.0% (125/133)
concordance. Discrepancies of results between SNP array
and karyotyping occurred in eight cases. SNP array revealed
all imbalanced chromosomal abnormalities and detected
additional aberrations in five cases (5/133, 3.8%) unidenti-
fied by karyotyping, which included one case with patho-
genic CNV (1/133, 0.8%), three cases with whole-genome
UPD (3/133, 2.3%), and one case (1/133, 0.8%) with a 4.3-
Mb del(4)(q35.1q35.2) and a 11.7-Mb dup(12)
(q24.31q24.33). However, balanced reciprocal translocations
presented in two cases, for which karyotypes were
46,XX,t(11;15)(p15.2;q11.2) and 46,XY,t(12;13)(p13;q22),
and tetraploidy, which presented in one case, was detected by
karyotyping instead of array. Additionally, two out of three
cases with mosaic aneuploidy were revealed by array but
recognized as pure trisomy by karyotyping (Table 1); another
case was detected as 48,XXY, þ9/47,XXY mosaicism by
both methods. Among the 22 cases with failure of cell cul-
ture due to bacterial pollution or no growth, SNP array
succeeded in 86.4% (19/22) cases and yielded a 50.0% (11/
22) abnormality rate.
In the SNP array study series, among 56 cases without
chromosome abnormalities (n ¼ 93) and UPD (n ¼ 3), 49
were found to be of various CNVs, with a total number of 95.
Thirty-eight out of the 95 CNVs (38/95, 40.0%) were classi-
fied as unique CNVs and 57 (57/95, 60.0%) as common
CNVs. Of the 38 unique CNVs (Tables 2 and S1), five were
recognized as likely benign CNVs due to the absence of genes,
one was considered as likely pathogenic CNV, and the other
32 were classified as VOUS. The likely pathogenic CNV was
located at 22q11.21 (18,919,477e21,800,471), completely
overlapping the known 22q11.2 microdeletion syndrome re-
gion. We confirmed this CNV as a de novo deletion after
performing FISH on both POC and peripheral blood from
parents.
Fig. 1. Frequency of various abnormalities detected by SNP array. Trisomy was the major abnormality, accounting for 64.9% (63/97) of all abnormalities.
Monosomy accounted for 12.4% (12/97), including monosomy X (n ¼ 11) and monosomy 21 (n ¼ 1). Other chromosome abnormalities accounted for 23%
(18/97), including triploidy (n ¼ 6), double trisomy (n ¼ 4), mosaicism (n ¼ 3), deletion/duplication (n ¼ 3), monosomy plus trisomy (n ¼ 2). Whole-genome
UPD (n ¼ 3) and likely pathogenic CNVs (n ¼ 1) accounted for 3.1% and 1.0%, respectively. CNV ¼ copy number variation; SNP ¼ single nucleotide
polymorphism; UPD ¼ uniparental disomy.
Table 1
Comparison of SNP array and karyotyping results in 155 POC samples.
G-banded karyotyping
Normal Chromosomal abnormality Failure Total
SNP array Normal 44 3a 8 55
Chromosomal abnormality 1b 81c 11 93
Pathogenic CNV 1 0 0 1
UPD 3 0 0 3
Failure 0 0 3 3
Total 49 84 22 155
CNV ¼ copy number variation; POC ¼ products of conception; SNP ¼ single nucleotide polymorphism; UPD ¼ uniparental disomy.
a Two cases with balanced reciprocal translocation and one case with tetraploidy.
b Arr 4q35.1q35.2 (186,511,421e190,806,055)  1, 12q24.31q24.33 (122,091,931e133,777,562)  3.
c One case with arr(2)  2.35, (X)  2, and one case with arr(18)  2.37, (XY)  1 were not diagnosed as mosaicism, but as trisomy 2 and trisomy 18 separately
by karyotyping.
Table 2
Summary of 38 unique CNVs detected in 30 cases with normal karyotypes.
Description Properties CNV count
Size (210e2881 kb) 200e400 kb 18
400e1000 kb 13
1e2.88 Mb 7
Gene content  1 coding gene 33
 1 OMIM gene 16
No gene 5
Chromosomal location Autosome 35
Sex chromosome 3
Type of CNV Duplication 31
Deletion 6
Amplification 1
CNV ¼ copy number variation.
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Compared with conventional G-banded karyotyping, we
employed SNP array to identify genetic aberrations in 155
POC specimens. Overall, both methods showed 94.0% (125/
133) concordance, but the SNP array achieved a higher
detection success rate than karyotyping (98.1% vs. 85.8%) and
enabled the detection of submicroscopic chromosomal ab-
normalities and UPD. Many factors, including cell culture
failure, poor chromosome morphology, selective growth of
abnormal cell lines or maternal cells, and subjective error of
technicians, could influence the success rate or accuracy of
conventional karyotyping. In our study, it seemed that the
lower success rate of karyotyping mainly came from cell
culture failure because of bacterial contamination or decreased
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specimens. However, DNA-based array using uncultured cells
could overcome these limitations, as shown in this study that
SNP array succeeded in 86.4% of cases that failed in cell
culture. SNP array obtained 3.8% additional aberrations over
karyotyping, including whole-genome UPD, pathogenic CNV,
and small chromosomal deletion/duplication in 2.3%, 0.8%,
and 0.8% cases, respectively. Frequencies of additional aber-
rations were similar to those reported in previous studies that
were based on array-CGH or SNP array methods.2,12
In general, there was an agreement between array and
karyotyping results on frequencies of various chromosome
abnormalities, of which aneuploidy was the primary abnor-
mality detected in POC. These were not different from those
of previous studies. However, discrepancies between SNP
array and karyotyping results occurred in cases with CNVs,
UPD, mosaicism, tetraploidy, deletion/duplication, and
balanced reciprocal translocation.
Normal embryonic development is controlled by genes.
CNV can convey phenotypes through influencing gene
expression levels, which results from whole gene copy number
change or disruption of part of a gene.17 Several studies have
indicated that CNVs existed in 1e13% of miscarriage
cases.6e10,18 Recently, two studies showed that potentially
pathogenic CNVs were present in 6e15% of POC samples by
analyzing the content and function of certain genes within
CNVs.5,15 Another study using SNP array to investigate a
large-scale cohort of POC samples revealed potentially path-
ogenic CNVs in 1.6% of cases.12 However, at present, because
data about clinical significance of most CNVs were deter-
mined through genotypeephenotype correlation of individuals
with clinical features, it was difficult to define whether or not
CNVs were pathogenic in most POC specimens without any
recognizable phenotypes. Some cases of VOUS were taken as
pathogenic because they could not be proved to be benign in
many previous studies.19 In this study, 38 unique CNVs were
identified, but 32 were classified as VOUS. It was based on
such opinions that no CNV databases or literature reported
these CNVs as pathogenic CNVs related to miscarriages or
human developmental disorders. However, some of these
CNVs carried genes related to embryonic development in
biological function and others carried genes of unknown
function.16 Only one de novo CNV loss of 2.88 Mb at
22q11.21 was considered to be a likely pathogenic CNV. It
completely overlapped the known pathogenic 22q11.2
microdeletion syndrome, which encompasses the phenotypes
of DiGeorge syndrome and velocardiofacial syndrome,
including but not limited to developmental delay and major
congenital heart disease. At present, however, because no case
with 22q11.2 microdeletion syndrome had been reported to be
associated with human miscarriage, its relationship with
miscarriage was still not clear. Sufficient evidence is lacking to
confirm that miscarriage was caused by the change of various
genes within this region in a correlative way. Therefore, for
purposes of identifying the clinical significance of CNVs
found in POC, further prospective studies are required to
reveal and accumulate information on CNVs.UPD is defined as the inheritance of both homologs of a
chromosome pair from a single parent with no representative
copy inherited from the other parent.20 SNP array, as a
genome-wide scanning tool based on SNP genotyping abil-
ity, would detect the majority of cases of UPD.20 Some types
of UPD are associated with imprinting disorders, such as
PradereWilli syndrome, Angelman syndrome, and Beck-
witheWiedemann syndrome, which often cause develop-
mental delay, intellectual disability, and malformations.
However, UPD also causes abnormal embryonic/fetal
development or even miscarriage, although the frequency of
UPD-associated miscarriage may be low, which was esti-
mated to occur in < 3% of miscarriage cases.21,22 Several
studies found that UPDs, for example, with maternal uni-
parentalheterodisomy of chromosome 9,21 paternal UPD of
chromosome 14,22 maternal uniparentalisodisomy and uni-
parentalheterodisomy of chromosome 16,23 and paternal
uniparentalisodisomy of chromosome 21,21 could cause
miscarriage. Moreover, it was well known that whole-
genome UPD was not compatible with life, and paternal
origin would lead to complete hydatidiform mole, resulting
in embryonic death.24 Although most cases of hydatidiform
mole could be identified by ultrasonography, very few cases
would cause confusion under ultrasound during early preg-
nancy. As shown in our study, ultrasonography made ques-
tionable diagnoses of embryo damage and villi edema in
three cases. Hence, their POC samples were sent to our
laboratory for SNP array analysis and were finally identified
as whole-genome UPD. Being limited by insufficient speci-
mens, we were unable to investigate the parental source of
UPD further. However, other parts of these POC were
simultaneously sent for pathological examination, and they
were confirmed to be complete hydatidiform moles,
demonstrating the paternal origin of the three UPD
indirectly.
Three cases with mosaicism were detected by SNP array,
while only one could be detected by karyotyping with a lower
proportion of mosaic. In addition, FISH also confirmed the
mosaicism. Two missed cases of mosaicism underlined two
important limitations of karyotyping, including the disadvan-
tage of cell culture and subjective error of karyotyping anal-
ysis.6 Subjective errors may result from fewer metaphase cells
or poor metaphase spreads. In such a situation, some aberra-
tions are often selectively ignored or could not be found by the
reviewing technician. As shown in this study, one case with 4.3
Mb deletion at 4q35.1q35.2 and 11.68 Mb duplication at
12q24.31q24.33 was missed by routine G-banded karyotyping
due to poor chromosome morphology or lower resolution,
although resolution of G-banding could reach 5e10 Mb in
theory. Moreover, selective growth of maternal cells or
abnormal cells occurring during cell culture may result in false
mosaicism, true mosaicism with incorrect proportion, or even
inaccurate karyotype.6,25 Therefore, these also demonstrated
that SNP array was more objective and sensitive than kar-
yotyping in the detection of mosaicism. Notably, it was re-
ported that only 23% of mosaicism detected in POC was
confirmed in fetuses, and most mosaicism was shown to be
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mosaicism is difficult to distinguish from true mosaicism in
clinical practice, it should be taken into consideration for
further investigation and interpretation of results.
Based on genotyping ability, SNP array not only identified
UPD, but also triploidy and some types of tetraploidy. In our
study, one case with tetraploidy was detected by karyotyping,
but not by array. According to different parental origins,
tetraploidy can be divided into two different types: 2:2 tetra-
ploidy (more common) and 3:1 tetraploidy (less common).
There is a limitation that SNP array is able to detect 3:1
tetraploidy (3 sets of chromosomes from 1 parent and 1 from
the other) but not 2:2 tetraploidy.11 Hence, it might be spec-
ulated that tetraploidy present in this case was consistent with
the type of 2:2 tetraploidy.
Overall, this study demonstrated that SNP array had certain
advantages over G-banded karyotyping in the detection of
CNVs, UPD, and mosaicism, but had disadvantages in
detection of balanced structural abnormalities and most
tetraploidy. Therefore, since SNP array achieved a higher
success rate in the experiments and yielded more information
about genetic aberrations in POC, it can be considered an
alternative method to karyotyping.
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